• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CTLA-4 +49 G/A,一个功能性的 1 型糖尿病风险 SNP,影响 Treg 亚群中的 CTLA-4 水平和 IA-2A 阳性,但不影响β细胞功能。

CTLA-4 +49 G/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function.

机构信息

Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

出版信息

Sci Rep. 2018 Jul 4;8(1):10074. doi: 10.1038/s41598-018-28423-9.

DOI:10.1038/s41598-018-28423-9
PMID:29973665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6031668/
Abstract

To investigate whether CTLA-4 +49 G/A (rs231775), a tagSNP in Asian, is a functional T1D SNP, we genotyped this SNP with 1035 T1D patients and 2575 controls in Chinese Han population. And 1280 controls measured insulin release and sensitivity based on an oral glucose tolerance test; 283 newly diagnosed T1D patients assayed C-peptide level based on a mixed-meal tolerance test. 31 controls were analyzed for different T cell subsets by multi-color flow cytometry. Under additive model, we found that CTLA-4 +49 G/A was significantly associated with T1D (P = 2.82E-04, OR = 1.25, 95% CI: 1.12-1.41), which was further confirmed by meta-analysis (P = 1.19E-08, OR = 1.65, 95% CI: 1.38-1.96) in Chinese Han population. Although we did not find any association between this SNP and beta-cell function in either healthy individuals or newly diagnosed T1D patients, healthy individuals carrying GG/GA genotypes had lower CTLA-4 expression in naïve or activated CD4 Treg subsets (P = 0.0046 and 0.0317 respectively). A higher positive rate of IA-2A was observed among T1D patients with GG genotype compared with AA (OR = 0.51, 95% CI: 0.30-0.84, p = 0.008). Collectively, CTLA-4 +49 G/A reached a GWAS significant association with T1D risk in Chinese Han population, affects CTLA-4 expression in Treg subsets and subsequently humoral immunity in T1D patients.

摘要

为了研究 CTLA-4 +49 G/A(rs231775),亚洲的一个标签 SNP 是否是功能性 T1D SNP,我们在汉族人群中对 1035 名 T1D 患者和 2575 名对照进行了该 SNP 的基因分型。1280 名对照者进行了口服葡萄糖耐量试验以测量胰岛素释放和敏感性;283 名新诊断的 T1D 患者进行了混合餐耐量试验以测定 C 肽水平。31 名对照者通过多色流式细胞术分析了不同的 T 细胞亚群。在加性模型下,我们发现 CTLA-4 +49 G/A 与 T1D 显著相关(P = 2.82E-04,OR = 1.25,95%CI:1.12-1.41),这在汉族人群的荟萃分析中得到了进一步证实(P = 1.19E-08,OR = 1.65,95%CI:1.38-1.96)。尽管我们在健康个体或新诊断的 T1D 患者中均未发现该 SNP 与胰岛β细胞功能之间存在任何关联,但携带 GG/GA 基因型的健康个体在幼稚或激活的 CD4 Treg 亚群中的 CTLA-4 表达较低(P = 0.0046 和 0.0317 分别)。与 AA 相比,GG 基因型的 T1D 患者中 IA-2A 的阳性率更高(OR = 0.51,95%CI:0.30-0.84,p = 0.008)。总体而言,CTLA-4 +49 G/A 在汉族人群中与 T1D 风险达到了 GWAS 显著关联,影响 Treg 亚群中的 CTLA-4 表达,并随后影响 T1D 患者的体液免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2b4/6031668/b650ee9f8f10/41598_2018_28423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2b4/6031668/9365fa704c35/41598_2018_28423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2b4/6031668/b650ee9f8f10/41598_2018_28423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2b4/6031668/9365fa704c35/41598_2018_28423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2b4/6031668/b650ee9f8f10/41598_2018_28423_Fig2_HTML.jpg

相似文献

1
CTLA-4 +49 G/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function.CTLA-4 +49 G/A,一个功能性的 1 型糖尿病风险 SNP,影响 Treg 亚群中的 CTLA-4 水平和 IA-2A 阳性,但不影响β细胞功能。
Sci Rep. 2018 Jul 4;8(1):10074. doi: 10.1038/s41598-018-28423-9.
2
The association between rs1893217, rs478582 in PTPN2 and T1D risk with different diagnosed age, and related clinical characteristics in Chinese Han population.rs1893217、rs478582 位点与中国汉族人群 1 型糖尿病发病年龄及相关临床特征的相关性。
Autoimmunity. 2019 Mar;52(2):95-101. doi: 10.1080/08916934.2019.1608191. Epub 2019 Apr 29.
3
Association of variants in PTPN22, CTLA-4, IL2-RA, and INS genes with type 1 diabetes in Emiratis.PTPN22、CTLA-4、IL2-RA 和 INS 基因变异与阿联酋 1 型糖尿病的关联。
Ann Hum Genet. 2021 Mar;85(2):48-57. doi: 10.1111/ahg.12406. Epub 2020 Sep 24.
4
CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.CTLA-4 +49 G/A多态性赋予自身免疫性疾病风险:一项更新的荟萃分析。
Genet Test Mol Biomarkers. 2017 Apr;21(4):222-227. doi: 10.1089/gtmb.2016.0335. Epub 2017 Feb 17.
5
Association of CTLA-4 and CD28 Gene Polymorphisms with Type 1 Diabetes in South Indian Population.CTLA-4 和 CD28 基因多态性与南印度人群 1 型糖尿病的关联。
Immunol Invest. 2019 Aug;48(6):659-671. doi: 10.1080/08820139.2019.1590395. Epub 2019 May 16.
6
Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.在中国汉族1型糖尿病患者及其亲属中,胰岛自身抗体与HLA - DQ基因型相关。
Tissue Antigens. 2007 Nov;70(5):369-75. doi: 10.1111/j.1399-0039.2007.00916.x.
7
The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.细胞毒性 T 淋巴细胞相关抗原 4 + 49A/G 及 CT60 多态性与中国成年 1 型糖尿病及隐匿性自身免疫性糖尿病的相关性。
J Endocrinol Invest. 2015 Feb;38(2):149-54. doi: 10.1007/s40618-014-0162-x. Epub 2014 Sep 4.
8
Association of CTLA-4 gene 49A/G polymorphism with the incidence of type 1 diabetes mellitus in the Iranian Kurdish population.伊朗库尔德人群中CTLA-4基因49A/G多态性与1型糖尿病发病率的关联
Pak J Biol Sci. 2013 Dec 15;16(24):1929-35. doi: 10.3923/pjbs.2013.1929.1935.
9
Expression of B7 and CD28 family genes in newly diagnosed type 1 diabetes.B7 和 CD28 家族基因在新诊断的 1 型糖尿病中的表达。
Hum Immunol. 2013 Oct;74(10):1251-7. doi: 10.1016/j.humimm.2013.07.007. Epub 2013 Jul 31.
10
Rs2227982 and rs2227981 in PDCD1 gene are functional SNPs associated with T1D risk in East Asian.PDCD1 基因中的 rs2227982 和 rs2227981 是与东亚人群 1 型糖尿病风险相关的功能性 SNPs。
Acta Diabetol. 2018 Aug;55(8):813-819. doi: 10.1007/s00592-018-1152-9. Epub 2018 May 17.

引用本文的文献

1
Identifying genetically predisposed type 1 diabetes mellitus individuals in a Southern Brazilian population: The construction of a genetic risk score.在巴西南部人群中识别遗传易感性1型糖尿病个体:构建遗传风险评分。
Genet Mol Biol. 2025 Apr 18;48(2):e20230308. doi: 10.1590/1678-4685-GMB-2023-0308. eCollection 2025.
2
Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes.1型糖尿病中调节性T细胞的失调与治疗前景
Acta Diabetol. 2025 Mar 21. doi: 10.1007/s00592-025-02478-3.
3
Plasticity deficits of Tregs remodeling toward Th1-like and Th17-like Tregs in individuals with type 1 diabetes.

本文引用的文献

1
Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.LRBA 缺陷患者滤泡辅助性 T 细胞反应过度,由 CTLA4 介导的调节失败引起。
J Allergy Clin Immunol. 2018 Mar;141(3):1050-1059.e10. doi: 10.1016/j.jaci.2017.05.022. Epub 2017 Jun 7.
2
Pathogenic implications for autoimmune mechanisms derived by comparative eQTL analysis of CD4+ versus CD8+ T cells.通过对CD4+与CD8+ T细胞进行比较性eQTL分析得出的自身免疫机制的致病意义。
PLoS Genet. 2017 Mar 1;13(3):e1006643. doi: 10.1371/journal.pgen.1006643. eCollection 2017 Mar.
3
Genetic risk factors for type 1 diabetes.
1型糖尿病患者中调节性T细胞向Th1样和Th17样调节性T细胞重塑的可塑性缺陷
J Endocrinol Invest. 2025 Mar 3. doi: 10.1007/s40618-025-02557-w.
4
Research progress of autoimmune diseases based on induced pluripotent stem cells.基于诱导多能干细胞的自身免疫性疾病研究进展。
Front Immunol. 2024 Apr 24;15:1349138. doi: 10.3389/fimmu.2024.1349138. eCollection 2024.
5
Effect of SIRT1 gene single-nucleotide polymorphisms on susceptibility to type 1 diabetes in a Han Chinese population.SIRT1 基因单核苷酸多态性对汉族 1 型糖尿病易感性的影响。
J Endocrinol Invest. 2024 Apr;47(4):819-826. doi: 10.1007/s40618-023-02190-5. Epub 2023 Sep 11.
6
Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases.检查点免疫疗法的免疫相关不良反应及其对癌症和自身免疫性疾病患者治疗的影响。
Front Immunol. 2023 Jun 5;14:1197364. doi: 10.3389/fimmu.2023.1197364. eCollection 2023.
7
A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors.推进免疫检查点抑制剂相关糖尿病知识的共识愿景。
Int J Mol Sci. 2023 Apr 21;24(8):7630. doi: 10.3390/ijms24087630.
8
Genetic variants and risk of endocrine autoimmunity in relatives of patients with Addison's disease.阿狄森氏病患者亲属的基因变异与内分泌自身免疫风险
Endocr Connect. 2023 May 8;12(6). doi: 10.1530/EC-23-0008. Print 2023 Jun 1.
9
Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children.调节性 T 细胞(Treg)与 Th17 淋巴细胞之间的免疫平衡是儿童 1 型糖尿病进展的关键因素。
Front Immunol. 2022 Aug 24;13:958430. doi: 10.3389/fimmu.2022.958430. eCollection 2022.
10
Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function.先天与后天:FOXP3、遗传与组织微环境塑造 Treg 功能。
Front Immunol. 2022 Aug 12;13:911151. doi: 10.3389/fimmu.2022.911151. eCollection 2022.
1 型糖尿病的遗传风险因素。
Lancet. 2016 Jun 4;387(10035):2331-2339. doi: 10.1016/S0140-6736(16)30582-7.
4
Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.细胞毒性T淋巴细胞相关蛋白4(CTLA4)基因多态性与儿童及成人自身免疫性甲状腺疾病的关联:病例对照研究
PLoS One. 2016 Apr 25;11(4):e0154394. doi: 10.1371/journal.pone.0154394. eCollection 2016.
5
Cell Type-Specific Regulation of Immunological Synapse Dynamics by B7 Ligand Recognition.B7配体识别对免疫突触动力学的细胞类型特异性调节
Front Immunol. 2016 Feb 4;7:24. doi: 10.3389/fimmu.2016.00024. eCollection 2016.
6
Genes affecting β-cell function in type 1 diabetes.影响1型糖尿病β细胞功能的基因。
Curr Diab Rep. 2015 Nov;15(11):97. doi: 10.1007/s11892-015-0655-9.
7
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.1型糖尿病易感基因座的精细定位以及因果变异与淋巴样基因增强子共定位的证据。
Nat Genet. 2015 Apr;47(4):381-6. doi: 10.1038/ng.3245. Epub 2015 Mar 9.
8
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.遗传易患儿童中糖尿病相关自身抗体的6年发病率:TEDDY研究
Diabetologia. 2015 May;58(5):980-7. doi: 10.1007/s00125-015-3514-y. Epub 2015 Feb 10.
9
Confusing signals: recent progress in CTLA-4 biology.令人困惑的信号:CTLA-4生物学的最新进展
Trends Immunol. 2015 Feb;36(2):63-70. doi: 10.1016/j.it.2014.12.001. Epub 2015 Jan 9.
10
The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells.共抑制受体CTLA-4通过调节滤泡辅助性T细胞、滤泡调节性T细胞和调节性T细胞来控制B细胞反应。
Immunity. 2014 Dec 18;41(6):1026-39. doi: 10.1016/j.immuni.2014.12.005. Epub 2014 Dec 5.